Cadre Holdings, Inc.

CDRE ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Operating Activities
Net Income $44.1M $36.1M $38.6M $5.8M $12.7M $38.5M
Depreciation & Amortization $18.6M $16.4M $15.7M $15.7M $13.7M $14.7M
Depreciation $9.4M $7.2M $7.9M $6.9M $5.1M $5.5M
Amortization $9.2M $9.3M $7.8M $8.8M $8.6M $9.2M
Stock-Based Compensation $12.2M $8.4M $9.4M $31.9M $355.0K —
Net Cash from Operating Activities $63.7M $31.8M $73.2M $46.4M $40.1M $45.4M
Investing Activities
Capital Expenditures $6.9M $5.7M $6.7M $4.5M $2.8M $4.7M
Business Acquisitions $89.6M $141.8M — $55.5M — —
Net Cash from Investing Activities $-96.4M $-147.4M $-6.5M $-59.6M $-2.8M $19.8M
Financing Activities
Dividends Paid $15.4M $13.9M $12.0M $11.5M $12.8M —
Stock Repurchases — — — — — —
Net Cash from Financing Activities $31.6M $152.7M $-24.7M $24.5M $-6.6M $-64.9M
Net Change in Cash $394.0K $37.2M $42.4M $11.4M $31.0M $353.0K
Free Cash Flow $56.8M $26.1M $66.5M $41.9M $37.3M $40.7M